Skip to main content

Advertisement

Log in

Proteomics Reveals Plasma Biomarkers for Ischemic Stroke Related to the Coagulation Cascade

  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

Stroke has a high incidence rate and often leads to permanent disability, particularly if it is not treated promptly. However, no blood biomarkers for early diagnosis are available to date. Therefore, we sought to detect stroke-specific blood biomarkers by identifying proteins associated with the underlying coagulation mechanism, which accounts for more than 80% of all stroke cases. Protein profiling was performed using blood samples from 16 healthy controls and 18 patients who suffered a stroke as the discovery set. We identified upregulated proteins (> 1.5-fold change and p value < 0.05) in patients who suffered a stroke relative to the corresponding levels in healthy controls by nano-liquid chromatography-tandem mass spectrometry using data-independent acquisition based on sequential window acquisition of all theoretical mass spectra, which was developed to improve the consistency and accuracy of candidate proteins. Pathway analysis confirmed that the upregulated proteins were mainly involved in blood coagulation. Among these, we selected prothrombin, plasminogen, fibrinogen alpha-chain, and histidine-rich glycoprotein as candidate biomarkers. Multiple reaction monitoring analysis was performed on a validation set of 61 serum samples (31 healthy controls and 30 stroke patients) to assess the diagnostic value of the candidate biomarkers. All four proteins showed higher expression levels in patients with stroke than in healthy controls. The areas under the receiver operating characteristic curve were greater than 0.9, confirming their clinical value. These four blood coagulation proteins may help in diagnosing stroke more accurately and quickly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data Availability

Not applicable.

Code Availability

Not applicable.

References

  • Abdullah W, Idris S, Bashkar S, Hassan R (2009) Role of fibrinolytic markers in acute stroke. Singap Med J 50:604

    CAS  Google Scholar 

  • Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of org 10172 in acute stroke treatment. Stroke 24:35–41

    Article  Google Scholar 

  • Adamson J, Beswick A, Ebrahim S (2004) Is stroke the most common cause of disability? J Stroke Cerebrovasc Dis 13:171–177

    Article  Google Scholar 

  • Aisina R, Mukhametova L (2014) Structure and function of plasminogen/plasmin system Russian. J Bioorgan Chem 40:590–605

    Article  CAS  Google Scholar 

  • Anjo SI, Santa C, Manadas B (2017) SWATH-MS as a tool for biomarker discovery: From basic research to clinical applications. Proteomics 17:1600278

    Article  Google Scholar 

  • Balogun IO, Roberts LN, Patel R, Pathansali R, Kalra L, Arya R (2016) Thrombin generation in acute ischaemic stroke. Stroke Res Treat 2016:7940680

    PubMed  PubMed Central  Google Scholar 

  • Beretov J, Wasinger VC, Millar EK, Schwartz P, Graham PH, Li Y (2015) Proteomic analysis of urine to identify breast cancer biomarker candidates using a label-free LC-MS/MS approach. PLoS One 10:e0141876

    Article  Google Scholar 

  • Bertina RM (2009) The role of procoagulants and anticoagulants in the development of venous thromboembolism. Thromb Res 123:S41–S45

    Article  CAS  Google Scholar 

  • Boehme AK, Esenwa C, Elkind MS (2017) Stroke risk factors, genetics, and prevention. Circ Res 120:472–495

    Article  CAS  Google Scholar 

  • Chapin JC, Hajjar KA (2015) Fibrinolysis and the control of blood coagulation. Blood Rev 29:17–24

    Article  CAS  Google Scholar 

  • Chuang S-Y, Bai C-H, Chen W-H, Lien L-M, Pan W-H (2009) Fibrinogen independently predicts the development of ischemic stroke in a Taiwanese population: CVDFACTS study. Stroke 40:1578–1584

    Article  CAS  Google Scholar 

  • Colwell M, Ahmed N, Butkowski R (2017) Detection of histidine-rich glycoprotein and fibrinogen with nickel-enzyme conjugates: purification of rabbit HRG. Anal Biochem 525:67–72

    Article  CAS  Google Scholar 

  • Dagonnier M, Cooke IR, Faou P, Sidon TK, Dewey HM, Donnan GA, Howells DW (2017) Discovery and longitudinal evaluation of candidate biomarkers for ischaemic stroke by mass spectrometry-based proteomics. Biomark Insights 12:1177271917749216

    Article  Google Scholar 

  • Dawson J, Walters M, Delles C, Mischak H, Mullen W (2012) Urinary proteomics to support diagnosis of stroke. PLoS One 7:e35879

    Article  CAS  Google Scholar 

  • Di Napoli M, Singh P (2009) Is plasma fibrinogen useful in evaluating ischemic stroke patients? Why, how, and when. Am Heart Assoc,

  • Eidelman RS, Hennekens CH (2003) Fibrinogen: a predictor of stroke and marker of atherosclerosis. Oxford University Press 24:499–500

  • Han NY, Choi W, Park JM, Kim EH, Lee H, Hahm KB (2013) Label-free quantification for discovering novel biomarkers in the diagnosis and assessment of disease activity in inflammatory bowel disease. J Dig Dis 14:166–174

    Article  CAS  Google Scholar 

  • Jickling GC, Sharp FR (2015) Biomarker panels in ischemic stroke. Stroke 46:915–920

    Article  Google Scholar 

  • Kim H et al (2013) Development of biomarkers for screening hepatocellular carcinoma using global data mining and multiple reaction monitoring. PLoS One 8:e63468

    Article  Google Scholar 

  • Lee S-J, Hong JM, Lee SE, Kang DR, Ovbiagele B, Demchuk AM, Lee JS (2017) Association of fibrinogen level with early neurological deterioration among acute ischemic stroke patients with diabetes. BMC Neurol 17:101

    Article  Google Scholar 

  • Lobo MDP, Moreno FBMB, Souza GHMF, Verde SMML, Moreira RDA, Monteiro-Moreira ACDO (2017) Label-free proteome analysis of plasma from patients with breast cancer: stage-specific protein expression. Front Oncol 7:14

    Article  Google Scholar 

  • Ma Y, Liu Y, Zhang Z, Yang G-Y (2019) Significance of complement system in ischemic stroke: a comprehensive review. Aging Dis 10:429–462

    Article  Google Scholar 

  • Macko RF et al (1999) Elevated tissue plasminogen activator antigen and stroke risk: the stroke prevention in young women study. Stroke 30:7–11

    Article  CAS  Google Scholar 

  • Maino A, Rosendaal FR, Algra A, Peyvandi F, Siegerink B (2015) Hypercoagulability is a stronger risk factor for ischaemic stroke than for myocardial infarction: a systematic review. PLoS One 10:e0133523

    Article  Google Scholar 

  • Millán M, Dorado L, Dávalos A (2010) Fibrinolytic therapy in acute stroke. Curr Cardiol Rev 6:218–226

    Article  Google Scholar 

  • Opartkiattikul N (1999) Standardization of coagulation tests. Southeast Asian J Trop Med Publ Health 30:79–85

    Google Scholar 

  • Pan S, Zhan X, Su X, Guo L, Lv L, Su B (2011) Proteomic analysis of serum proteins in acute ischemic stroke patients treated with acupuncture. Exp Biol Med 236:325–333

    Article  CAS  Google Scholar 

  • Parker CE, Borchers CH (2014) Mass spectrometry based biomarker discovery, verification, and validation—quality assurance and control of protein biomarker assays. Mol Oncol 8:840–858

    Article  CAS  Google Scholar 

  • Poon IK, Patel KK, Davis DS, Parish CR, Hulett MD (2011) Histidine-rich glycoprotein: the Swiss Army knife of mammalian plasma. Blood 117:2093–2101

    Article  CAS  Google Scholar 

  • Rifai N, Gillette MA, Carr SA (2006) Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 24:971

    Article  CAS  Google Scholar 

  • Rothwell PM, Howard SC, Power DA, Gutnikov SA, Algra A, van Gijn J, Clark TG, Murphy MFG, Warlow CP (2004) Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5113 patients with transient ischemic attack and minor ischemic stroke. Stroke 35:2300–2305

    Article  CAS  Google Scholar 

  • Saadatnia M, Salehi M, Amini G, Miri NSA (2012) The impact of prothrombin (G20210A) gene mutation on stroke in youths. ARYA Atherosc 8:9

    Google Scholar 

  • Sharma R et al. (2015) Proteomic signature of endothelial dysfunction identified in the serum of acute ischemic stroke patients by the iTRAQ-based LC–MS approach J Proteome Res 14:2466-2479

  • Stoll G, Kleinschnitz C, Nieswandt B (2008) Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment. Blood 112:3555–3562

    Article  CAS  Google Scholar 

  • ten Cate H, Hemker HC (2016) Thrombin generation and atherothrombosis: what does the evidence indicate? J Am Heart Assoc 5:e003553

    PubMed  PubMed Central  Google Scholar 

  • Thomas S, Hao L, Ricke WA, Li L (2016) Biomarker discovery in mass spectrometry-based urinary proteomics. PROTEOMICS–Clin Appl 10:358–370

    Article  CAS  Google Scholar 

  • Vu TT, Stafford AR, Leslie BA, Kim PY, Fredenburgh JC, Weitz JI (2011) Histidine-rich glycoprotein binds fibrin (ogen) with high affinity and competes with thrombin for binding to the γ′-chain. J Biol Chem 286:30314–30323

    Article  CAS  Google Scholar 

  • Wildsmith KR et al (2014) Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics. Mol Neurodegener 9:22

    Article  Google Scholar 

  • Yakovlev S, Makogonenko E, Kurochkina N, Nieuwenhuizen W, Ingham K, Medved L (2000) Conversion of fibrinogen to fibrin: mechanism of exposure of tPA-and plasminogen-binding sites. Biochemistry 39:15730–15741

    Article  CAS  Google Scholar 

  • Yannell KE, Ferreira CR, Tichy SE, Cooks RG (2018) Multiple reaction monitoring (MRM)-profiling with biomarker identification by LC-QTOF to characterize coronary artery disease. Analyst 143:5014–5022

    Article  CAS  Google Scholar 

  • Zimmermann-Ivol CG, Burkhard PR, Le Floch-Rohr J, Allard L, Hochstrasser DF, Sanchez J-C (2004) Fatty acid binding protein as a serum marker for the early diagnosis of stroke: a pilot study. Mol Cell Proteomics 3:66–72

    Article  CAS  Google Scholar 

Download references

Funding

This research was supported by the Bio & Medical Technology Development Program of the NRF funded by the Korean government, MSIP (Grant No. 2016M3A9B694241).

Author information

Authors and Affiliations

Authors

Contributions

J.L. and S.M. wrote the manuscript, created the figures and the table, and generated proteomic data. A.P., D.K., Y.J.L., H.J.K., H.C., M.S., S.J., J.G., and Y.T.J. performed sample preparation and generated proteomic data. H.G.K. conceived the study and was in charge of overall direction and planning. All the authors discussed the results and have approved the manuscript for publishing.

Corresponding author

Correspondence to Hee-Gyoo Kang.

Ethics declarations

Conflict of Interest

The authors declare that they have no competing interests.

Ethics Approval

All samples were obtained from Eulji University, Daejeon, Korea. This study was approved by the local institutional review board (EMC 2016-03-019).

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, J., Mun, S., Park, A. et al. Proteomics Reveals Plasma Biomarkers for Ischemic Stroke Related to the Coagulation Cascade. J Mol Neurosci 70, 1321–1331 (2020). https://doi.org/10.1007/s12031-020-01545-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12031-020-01545-4

Keywords

Navigation